Cargando…
Severe thrombocytopenia after trastuzumab retreatment: a case report
BACKGROUND: Trastuzumab prolongs survival of human epidermal growth factor receptor 2-positive breast cancer patients in both the adjuvant and metastatic settings. Currently toxicity data are not available on retreatment of metastatic breast cancer patients who relapse after adjuvant trastuzumab. We...
Autores principales: | Pino, Maria Simona, Angiolini, Catia, Fioretto, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851485/ https://www.ncbi.nlm.nih.gov/pubmed/24093447 http://dx.doi.org/10.1186/1756-0500-6-400 |
Ejemplares similares
-
Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
por: Zhou, Qiong, et al.
Publicado: (2020) -
Severe thrombocytopenia related to trastuzumab infusion
por: Mantzourani, Marina, et al.
Publicado: (2011) -
Non-Surgical Retreatment After Failed Intentional Replantation: A Case Report
por: Ong, Teng Kai
Publicado: (2019) -
Severe isolated thrombocytopenia after clopidogrel and pentoxifylline therapy: a case report
por: Vedes, Elisa Celeste da Silva, et al.
Publicado: (2011) -
A Case Report with Severe Thrombocytopenia Induced by Axitinib
por: Koksal, Ulkuhan I., et al.
Publicado: (2020)